Logos Global Management »

Vor Biopharma shares owned by Logos Global Management

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 100k 13.08

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences (IDYA)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Erasca (ERAS)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Tango Therapeutics (TNGX)
Avidity Biosciences Ord (RNA)
Biogen Idec (BIIB)
Immunovant (IMVT)

View all positions for Logos Global Management

Top funds holding Vor Biopharma

Susquehanna International
RA Capital Management
VR Adviser
Caligan Partners
Vanguard Group
Shay Capital
Fcpm Iii Services B.v.
Laurion Capital Management
UBS Group
FMR
Geode Capital Management
Goldman Sachs Group
Belvedere Trading
Logos Global Management
State Street Corporation

View all funds holding Vor Biopharma